PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.35%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.23%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.23%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.74%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-23.91%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.77%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
1.80%
Dividend growth under 50% of ON's 120.93%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-34.44%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
49.18%
Positive 10Y revenue/share CAGR while ON is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
130.13%
Positive 5Y CAGR while ON is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
30.62%
Positive 3Y CAGR while ON is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
101.41%
Positive long-term OCF/share growth while ON is negative. John Neff would see a structural advantage in sustained cash generation.
146.61%
5Y OCF/share CAGR at 50-75% of ON's 256.15%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
69.41%
3Y OCF/share CAGR 1.25-1.5x ON's 52.51%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
323.19%
Positive 10Y CAGR while ON is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1889.18%
5Y net income/share CAGR above 1.5x ON's 165.21%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
68.97%
Below 50% of ON's 189.93%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
181.93%
Positive growth while ON is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
25.48%
Below 50% of ON's 79.45%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.20%
Below 50% of ON's 73.09%. Michael Burry suspects a serious short-term disadvantage in building book value.
91.76%
Dividend/share CAGR of 91.76% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
106.54%
Dividend/share CAGR of 106.54% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
88.39%
3Y dividend/share CAGR at 50-75% of ON's 121.97%. Martin Whitman might see a weaker short-term approach to distributing cash.
-1.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.95%
Inventory is declining while ON stands at 0.28%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.29%
Negative asset growth while ON invests at 1.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.11%
Under 50% of ON's 25.38%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Our R&D shrinks while ON invests at 16.23%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.